XML 27 R17.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity
 9 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Stockholders' Equity STOCKHOLDERS’ EQUITY
AOCI
The following tables presents changes by component:
Three months ended March 31, 2024 and 2025
($000s)Foreign
Currency
Translation
Adjustment		Derivative
Valuation		Defined
Benefit Plan		Total
Balance, December 31, 2023$(6,282)$77 $72 $(6,133)
Foreign currency translation(288)— — (288)
Unrealized loss on cash flow hedges— (165)— (165)
Reclassifications to earnings— 34 — 34 
Balance, March 31, 2024$(6,570)$(54)$72 $(6,552)
($000s)Foreign
Currency
Translation
Adjustment		Derivative
Valuation		Defined
Benefit Plan		Total
Balance, December 31, 2024$(7,406)$(49)$205 $(7,250)
Foreign currency translation374 — — 374 
Unrealized loss on cash flow hedges— 343 — 343 
Reclassifications to earnings— 42 — 42 
Balance, March 31, 2025$(7,032)$336 $205 $(6,491)

Nine months ended March 31, 2024 and 2025
($000s)Foreign
Currency
Translation
Adjustment		Derivative
Valuation		Defined
Benefit Plan		Total
Balance, June 30, 2023$(6,260)$(124)$72 $(6,312)
Foreign currency translation(310)— — (310)
Unrealized loss on cash flow hedges— (35)— (35)
Reclassifications to earnings— 105 — 105 
Balance, March 31, 2024$(6,570)$(54)$72 $(6,552)
($000s)Foreign
Currency
Translation
Adjustment		Derivative
Valuation		Defined
Benefit Plan		Total
Balance, June 30, 2024$(7,883)$(235)$205 $(7,913)
Foreign currency translation851 — — 851 
Unrealized gain on cash flow hedges— 271 — 271 
Reclassifications to earnings— 300 — 300 
Balance, March 31, 2025$(7,032)$336 $205 $(6,491)

TRGI Purchase Agreement
On November 19, 2024, the Company entered the TRGI Purchase Agreement, pursuant to which the Company purchased from TRGI 3,562,341 issued and outstanding common shares of the Company for an aggregate price of $70 million, of which $45 million was paid in cash and $25 million was paid in the form of a convertible promissory note. The convertible promissory note was repaid on January 9, 2025.
Share repurchase programs

The Board may authorize share repurchases of the Company’s common shares and the Company had multiple share repurchase plans during the three and nine months ended March 31, 2025 and 2024. On November 19, 2024 and in connection with the TRGI Purchase Agreement, the Board terminated the Company's then-existing share repurchase program.
The Company did not repurchase any common shares during the three months ended March 31, 2025. During the nine months ended March 31, 2025, the Company repurchased 327,230 of its common shares totaling $5.6 million under existing share repurchase programs. During the three and nine months ended March 31, 2024, the Company repurchased 501,549 and 1,124,876 shares of its common shares for $8.1 million and $18.6 million, respectively. All repurchases under these programs were funded with our existing cash balance.